Cite
HARVARD Citation
Su, Y. et al. (2023). Recombinant human chorionic gonadotropin induces signaling pathways towards cancer prevention in the breast of BRCA1/2 mutation carriers. European journal of cancer prevention. 32 (2), pp. 126-138. [Online].